Yüklüyor......
Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen
The ability of immune-competent donor T cells to mediate a beneficial graft-versus-leukemia (GVL) effect was first identified in the setting of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for hematologic malignancies. Unfortunately, with the exception of chronic myelogenous leukem...
Kaydedildi:
| Yayımlandı: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5536093/ https://ncbi.nlm.nih.gov/pubmed/23233573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/asheducation-2012.1.143 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|